{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:30:47Z","timestamp":1790101847631,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1C1B2005982"],"award-info":[{"award-number":["2017R1C1B2005982"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B4005924"],"award-info":[{"award-number":["2017R1A2B4005924"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BK21-plus education program"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.08.041","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T10:01:38Z","timestamp":1533808898000},"page":"2792-2799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy"],"prefix":"10.1016","volume":"503","author":[{"given":"Jang-Hyuk","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jun","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Seok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-713X","authenticated-orcid":false,"given":"Chung-Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.08.041_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.bbrc.2018.08.041_bib2","first-page":"176","article-title":"Hydroxylation of HIF-1: oxygen sensing at the molecular level","volume":"19","author":"Semenza","year":"2004","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.bbrc.2018.08.041_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbrc.2018.08.041_bib4","first-page":"41","article-title":"Congenital anomalies of the retina","volume":"7","author":"Cogan","year":"1971","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.bbrc.2018.08.041_bib5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2018.08.041_bib6","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.08.041_bib7","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.08.041_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2018.08.041_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","article-title":"Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice","volume":"111","author":"Dal Monte","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2018.08.041_bib10","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1167\/iovs.12-9691","article-title":"Propranolol inhibition of beta-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy","volume":"53","author":"Chen","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2018.08.041_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2431-10-83","article-title":"Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491","volume":"10","author":"Filippi","year":"2010","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.bbrc.2018.08.041_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.7.11.8370472","article-title":"Pericyte physiology","volume":"7","author":"Shepro","year":"1993","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2018.08.041_bib13","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.51.10.3107","article-title":"Pericytes and the pathogenesis of diabetic retinopathy","volume":"51","author":"Hammes","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2018.08.041_bib14","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood-2011-01-331694","article-title":"Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression","volume":"118","author":"Franco","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.08.041_bib15","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2337\/db13-1942","article-title":"Angiopoietin 2 induces pericyte apoptosis via alpha3beta1 integrin signaling in diabetic retinopathy","volume":"63","author":"Park","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2018.08.041_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.exer.2008.12.015","article-title":"Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice","volume":"88","author":"Steinle","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2018.08.041_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1167\/iovs.04-1023","article-title":"Sympathetic innervation regulates basement membrane thickening and pericyte number in rat retina","volume":"46","author":"Wiley","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2018.08.041_bib18","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1096\/fj.201700570RR","article-title":"beta-Adrenergic receptor agonists attenuate pericyte loss in diabetic retinas through Akt activation","volume":"32","author":"Yun","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2018.08.041_bib19","doi-asserted-by":"crossref","first-page":"15296","DOI":"10.1038\/ncomms15296","article-title":"Plastic roles of pericytes in the blood-retinal barrier","volume":"8","author":"Park","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.08.041_bib20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/jcp.25575","article-title":"Endothelial STAT3 activation increases vascular leakage through downregulating tight junction proteins: implications for diabetic retinopathy","volume":"232","author":"Yun","year":"2017","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.bbrc.2018.08.041_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1290\/1071-2690(2002)038<0298:BBIAIC>2.0.CO;2","article-title":"Beta blockade induces apoptosis in cultured capillary endothelial cells","volume":"38","author":"Sommers Smith","year":"2002","journal-title":"In\u00a0Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.bbrc.2018.08.041_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SLA.0b013e318254ce7a","article-title":"Propranolol induces regression of hemangioma cells through HIF-1alpha-mediated inhibition of VEGF-A","volume":"256","author":"Chim","year":"2012","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbrc.2018.08.041_bib23","first-page":"48","article-title":"Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbrc.2018.08.041_bib24","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.jpedsurg.2012.09.008","article-title":"Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells","volume":"47","author":"Ji","year":"2012","journal-title":"J.\u00a0Pediatr. Surg."},{"key":"10.1016\/j.bbrc.2018.08.041_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","article-title":"Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment","volume":"2","author":"Pasquier","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.08.041_bib26","first-page":"5213","article-title":"Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2018.08.041_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.vph.2010.08.002","article-title":"Propranolol suppresses angiogenesis in\u00a0vitro: inhibition of proliferation, migration, and differentiation of endothelial cells","volume":"53","author":"Lamy","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.08.041_bib28","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1128\/JVI.01569-15","article-title":"Propranolol decreases proliferation of endothelial cells transformed by Kaposi's Sarcoma-associated herpesvirus and induces lytic viral gene expression","volume":"89","author":"McAllister","year":"2015","journal-title":"J.\u00a0Virol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18317212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18317212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T17:09:16Z","timestamp":1537808956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18317212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18317212"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.041","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}